Search for dialysis centres here

Find a centre Log in to explore the world's most comprehensive database of dialysis centres for free!

Jobs in dialysis

dialysis.team.logo.small.000 Professional dialysis recruitment 

 

Affymax Says FDA Advisory Committee To Review Peginesatide - Quick Facts - RTT News PDF Print

Affymax Says FDA Advisory Committee To Review Peginesatide - Quick Facts
RTT News
If approved, peginesatide will be the first once-monthly Erythropoiesis stimulating agent available for the treatment of anemia associated with chronic kidney disease patients on dialysis in the US. by RTT Staff Writer.
Affymax Announces FDA Advisory Committee to Review Peginesatide MarketWatch (press release)
FDA sets date to review Affymax anemia drug CNBC.com

all 18 news articles »

...
 
Share |

Dialysis travel

Dialysis information

Global Dialysis

Copyright © 2026 Global Dialysis. All Rights Reserved.